Daily reporting, analysis, and legal-market coverage across patents, trademarks, copyright, licensing, disputes, and policy.
333 articles matching your filters, newest first.
Practical patents context for IP teams tracking Patents, Secures Hong Kong Patent, Lung Cancer Detection Technology.
IIPLA reviews the patents implications of Patents, Secures Hong Kong Patent, Lung Cancer Detection Technology, with practical notes for China IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Practical copyright context for IP teams tracking Copyright, IGP Disu, NIPSS.
IIPLA reviews the copyright implications of Copyright, IGP Disu, NIPSS, with practical notes for Europe IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Practical ai & ip context for IP teams tracking AI & IP, Microsoft Director Privately Admitted, AI Was.
IIPLA reviews the ai & ip implications of AI & IP, Microsoft Director Privately Admitted, AI Was, with practical notes for USA IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Largest US solar manufacturer withdraws Section 337 complaint, refocuses on district court litigation following Trump-era trade actions
First Solar, the leading US solar panel manufacturer, has recalibrated its patent enforcement approach by voluntarily withdrawing its Section 337 complaint at the US International Trade Commission. This strategic pivot follows the Trump Administration’s imposition of a 15% tariff on polysilicon imports under Section 2…
Practical ai & ip context for IP teams tracking AI & IP, John Wiley Ends Lobbying, Relationship With Access Partnership.
IIPLA reviews the ai & ip implications of AI & IP, John Wiley Ends Lobbying, Relationship With Access Partnership, with practical notes for USA IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
The new filing aims to protect multiple facets of Ultrasome, enhancing Creative Medical’s intellectual property as it explores applications beyond osteoarthritis
Creative Medical Technology Holdings, Inc. has submitted a U.S. provisional patent application to expand intellectual property coverage for its proprietary Ultrasome cell-free regenerative medicine platform. The application encompasses product composition, biological potency, manufacturing controls, stability, deliver…
The granted patent complements existing Chinese intellectual property, reinforcing bioAffinity’s position in Asia’s lung cancer diagnostic landscape
bioAffinity Technologies has obtained a Hong Kong patent for its CyPath® Lung diagnostic technology, enhancing its patent portfolio alongside a recent Chinese patent. This dual protection supports the company’s strategy to address the significant lung cancer burden in Asia with its noninvasive, flow cytometry-based di…
Haynes and Boone to lead patent strategy and licensing efforts for Fabric.AI’s MicroLED-based Neural I/o™ technology, targeting AI data center efficiency enhancements
Fabric.AI has appointed Haynes and Boone, LLP as its intellectual property counsel to support the development and protection of Neural I/o™, a joint MicroLED optical interconnect technology with Kopin Corporation. This collaboration aims to address bandwidth and energy efficiency challenges in next-generation AI data…
New filing aims to protect product composition, manufacturing methods, and therapeutic uses following promising osteoarthritis pilot results
Creative Medical Technology Holdings has submitted a U.S. provisional patent application to broaden intellectual property coverage for its Ultrasome™ cell-free regenerative platform. The filing encompasses product composition, biological potency, manufacturing controls, stability, delivery methods, and therapeutic app…
EnergyPathways’ recent update on its intellectual property patent application has sparked renewed interest among UK investors amid a busy London trading session.
EnergyPathways (LON:EPP) has entered the spotlight after issuing a regulatory disclosure concerning its intellectual property patent application. This development provides a fresh, date-stamped update that market participants are using to reassess the company’s position within the broader context of sector activity an…
Fabric.AI retains top-tier IP counsel Haynes and Boone to support patent strategy and licensing for collaborative MicroLED optical interconnect innovations with Kopin Corporation
Fabric.AI, a Nasdaq-listed AI infrastructure firm, has appointed Haynes and Boone, LLP as intellectual property counsel to advance and protect the Neural I/O™ technology it co-develops with Kopin Corporation. This strategic move aims to establish a robust patent portfolio amid ongoing technical discussions with major…
Practical policy context for IP teams tracking Policy, Wave, GOV.UK.
IIPLA reviews the policy implications of Policy, Wave, GOV.UK, with practical notes for UK IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Generative AI lowers patent application barriers, fueling a sharp rise in individual filings and expanding Korean IP presence overseas
In the first half of 2024, South Korea experienced unprecedented growth in domestic patent and trademark applications, propelled by advances in artificial intelligence and semiconductor industries. The Ministry of Intellectual Property reported a 29.2% increase in patent filings and an 18.6% rise in trademark applicat…
Practical patents context for IP teams tracking Patents, TCI Entertainment Aligns, Globant.
IIPLA reviews the patents implications of Patents, TCI Entertainment Aligns, Globant, with practical notes for USA IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Practical patents context for IP teams tracking Patents, Manitoba, Winnipeg Sun Research Manitoba.
IIPLA reviews the patents implications of Patents, Manitoba, Winnipeg Sun Research Manitoba, with practical notes for Europe IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Landmark ruling clarifies statutory remuneration for service inventions, emphasizing annual operating profit over product lifecycle profitability
In a pivotal decision, China’s Supreme People’s Court resolved a dispute over inventor remuneration tied to a patented biosimilar adalimumab formulation. The court established that remuneration is owed based on annual operating profits generated by the patented invention’s commercial implementation, regardless of the…
The Chinese patent approval enhances Godavari’s global biopharmaceutical IP portfolio amid ongoing operational challenges in sugar and ethanol segments
Godavari Biorefineries has been granted a Chinese patent for chemical compounds that inhibit V-ATPase activity to treat viral infections, marking a significant advancement in its biopharmaceutical R&D pipeline. This patent complements existing Japanese and European patents but is unlikely to impact near-term earnings,…
Practical patents context for IP teams tracking Patents, After, HiberGene.
IIPLA reviews the patents implications of Patents, After, HiberGene, with practical notes for Europe IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.